In Vivo Tracking of Chemokine Receptor CXCR4-Engineered Mesenchymal Stem Cell Migration by Optical Molecular Imaging

CXCR4, the stromal cell-derived factor-1 receptor, plays an important role in the migration of hematopoietic progenitor/stem cells to injured and inflamed areas. Noninvasive cell tracking methods could be useful for monitoring cell fate. Therefore, in this study, we evaluated the efficacy of an intravenous infusion of genetically engineered mesenchymal stem cells (MSCs) overexpressing CXC chemokine receptor 4 (CXCR4) to home to the tumor, by optical imaging. We constructed a retroviral vector containing CXCR with dual reporter genes, eGFP and Fluc2, under the control of an EF1α promoter (pBABE-EF1α-CXCR4-eGFP-IRES-Fluc2). We also developed an eGFP-Fluc2 construct in the Retro-X retroviral vector (Retro-X-eGFP-Fluc2). MSCs were transduced with retroviruses to generate CXCR4-overexpressing MSCs (MSC-CXCR4/Fluc2) and MSCs (MSC/Fluc2). CXCR4 mRNA and protein expression was confirmed by RT-PCR and Western blotting, respectively, and it was higher in MSC-CXCR4/Fluc2 than in naive MSCs. eGFP expression was confirmed by confocal microscopy. The transfected MSC-CXCR4/Fluc2 cells showed higher migratory capacity than naive MSCs observed in Transwell migration assay. The in vivo migration of CXCR4-overexpressing MSCs to MDAMB231/Rluc tumor model by BLI imaging was also confirmed. Intravenous delivery of genetically modified MSCs overexpressing CXCR4 with a Fluc2 reporter gene may be a useful, noninvasive BLI imaging tool for tracking cell fate.

[1]  Joseph C. Wu,et al.  In vivo bioluminescence for tracking cell fate and function. , 2011, American journal of physiology. Heart and circulatory physiology.

[2]  F. Luyten,et al.  Bone marrow mesenchymal cells for haemophilia A gene therapy using retroviral vectors with modified long‐terminal repeats , 2003, Haemophilia : the official journal of the World Federation of Hemophilia.

[3]  M. Ashraf,et al.  Over-expression of CXCR4 on mesenchymal stem cells augments myoangiogenesis in the infarcted myocardium. , 2008, Journal of molecular and cellular cardiology.

[4]  L. Marquez-Curtis,et al.  Enhancing the Migration Ability of Mesenchymal Stromal Cells by Targeting the SDF-1/CXCR4 Axis , 2013, BioMed research international.

[5]  Yu-fang Shi,et al.  Mesenchymal stem cells: a new trend for cell therapy , 2013, Acta Pharmacologica Sinica.

[6]  Xiuli Wu,et al.  Overexpression of CXCR4 in mesenchymal stem cells promotes migration, neuroprotection and angiogenesis in a rat model of stroke , 2012, Journal of the Neurological Sciences.

[7]  S. Karlsson,et al.  Overexpression of CXCR4 on human CD34+ progenitors increases their proliferation, migration, and NOD/SCID repopulation. , 2004, Blood.

[8]  M. Pittenger,et al.  Multilineage potential of adult human mesenchymal stem cells. , 1999, Science.

[9]  Laura Smith,et al.  Multidrug-resistant breast cancer: current perspectives , 2014, Breast cancer.

[10]  R. Izadpanah,et al.  Biologic properties of mesenchymal stem cells derived from bone marrow and adipose tissue , 2006, Journal of cellular biochemistry.

[11]  I. Ghiran,et al.  Human Bone Marrow Stromal Cells Express a Distinct Set of Biologically Functional Chemokine Receptors , 2006, Stem cells.

[12]  Seok-Goo Cho,et al.  The potential use of mesenchymal stem cells in hematopoietic stem cell transplantation , 2013, Experimental & Molecular Medicine.

[13]  P. Conget,et al.  Mesenchymal progenitor cells in human umbilical cord blood , 2000, British journal of haematology.

[14]  Min Zhu,et al.  Human adipose tissue is a source of multipotent stem cells. , 2002, Molecular biology of the cell.

[15]  S. Kostin,et al.  Efficient homing of multipotent adult mesenchymal stem cells depends on FROUNT-mediated clustering of CCR2. , 2008, Cell stem cell.

[16]  Pegylated liposomal doxorubicin (Lipo-Dox®) combined with cyclophosphamide and 5-fluorouracil is effective and safe as salvage chemotherapy in taxane-treated metastatic breast cancer: an open-label, multi-center, non-comparative phase II study , 2015, BMC Cancer.

[17]  L. Ou,et al.  Targeted migration of mesenchymal stem cells modified with CXCR4 gene to infarcted myocardium improves cardiac performance. , 2008, Molecular therapy : the journal of the American Society of Gene Therapy.

[18]  E. Maiorano,et al.  Everolimus restrains the paracrine pro-osteoclast activity of breast cancer cells , 2015, BMC Cancer.

[19]  W. Vainchenker,et al.  Intracellular Localization and Constitutive Endocytosis of CXCR4 in Human CD34+ Hematopoietic Progenitor Cells , 2004, Stem cells.

[20]  R. Henschler,et al.  Biodistribution, migration and homing of systemically applied mesenchymal stem/stromal cells , 2016, Stem Cell Research & Therapy.

[21]  G. Chakravarty,et al.  Nelfinavir targets multiple drug resistance mechanisms to increase the efficacy of doxorubicin in MCF-7/Dox breast cancer cells. , 2016, Biochimie.

[22]  P. Delafontaine,et al.  Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. , 2009, Cell stem cell.

[23]  Jeong-Hwa Lee,et al.  In vivo near-infrared imaging for the tracking of systemically delivered mesenchymal stem cells: tropism for brain tumors and biodistribution , 2015, International journal of nanomedicine.

[24]  H. Klüter,et al.  Critical Parameters for the Isolation of Mesenchymal Stem Cells from Umbilical Cord Blood , 2004, Stem cells.

[25]  A. Vlahou,et al.  Molecular and proteomic characterization of human mesenchymal stem cells derived from amniotic fluid: comparison to bone marrow mesenchymal stem cells. , 2007, Stem cells and development.

[26]  Ying Liu,et al.  Radioactive 125I seeds inhibit cell growth and epithelial-mesenchymal transition in human glioblastoma multiforme via a ROS-mediated signaling pathway , 2015, BMC Cancer.

[27]  M. Ratajczak,et al.  Migration of Bone Marrow and Cord Blood Mesenchymal Stem Cells In Vitro Is Regulated by Stromal‐Derived Factor‐1‐CXCR4 and Hepatocyte Growth Factor‐c‐met Axes and Involves Matrix Metalloproteinases , 2006, Stem cells.

[28]  Guodong Pan,et al.  Mesenchymal stem cells participate in angiogenesis and improve heart function in rat model of myocardial ischemia with reperfusion. , 2006, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[29]  F. Z. Mouh,et al.  Recent Progress in Triple Negative Breast Cancer Research. , 2016, Asian Pacific journal of cancer prevention : APJCP.

[30]  H. Neumann,et al.  Bystander killing of malignant glioma by bone marrow-derived tumor-infiltrating progenitor cells expressing a suicide gene. , 2007, Molecular therapy : the journal of the American Society of Gene Therapy.

[31]  Sun Hwa Park,et al.  Migration of human umbilical cord blood mesenchymal stem cells mediated by stromal cell-derived factor-1/CXCR4 axis via Akt, ERK, and p38 signal transduction pathways. , 2010, Biochemical and biophysical research communications.

[32]  Byeong-Cheol Ahn,et al.  In Vivo Cell Tracking with Bioluminescence Imaging , 2015, Nuclear Medicine and Molecular Imaging.

[33]  M. Chopp,et al.  Different routes of administration of human umbilical tissue-derived cells improve functional recovery in the rat after focal cerebral ischemia , 2012, Brain Research.

[34]  Bing Liu,et al.  Human placenta-derived mesenchymal progenitor cells support culture expansion of long-term culture-initiating cells from cord blood CD34+ cells. , 2004, Experimental hematology.

[35]  J. Chang,et al.  Irradiation Enhances the Tumor Tropism and Therapeutic Potential of Tumor Necrosis Factor‐Related Apoptosis‐Inducing Ligand‐Secreting Human Umbilical Cord Blood‐Derived Mesenchymal Stem Cells in Glioma Therapy , 2010, Stem cells.

[36]  Robert A. Kloner,et al.  Systemic Delivery of Bone Marrow–Derived Mesenchymal Stem Cells to the Infarcted Myocardium: Feasibility, Cell Migration, and Body Distribution , 2003, Circulation.

[37]  YingWu,et al.  Human placenta-derived mesenchymal progenitor cells support culture expansion of long-term culture-initiating cells from cord blood CD34^＋ cells , 2005 .

[38]  Thomas Aigner,et al.  Articular cartilage repair by gene therapy using growth factor-producing mesenchymal cells. , 2003, Arthritis and rheumatism.

[39]  I. Bellantuono,et al.  A small proportion of mesenchymal stem cells strongly expresses functionally active CXCR4 receptor capable of promoting migration to bone marrow. , 2004, Blood.

[40]  F. Kloss,et al.  Bone regeneration in critical size defects by cell-mediated BMP-2 gene transfer: a comparison of adenoviral vectors and liposomes , 2003, Gene Therapy.

[41]  W. Koo,et al.  Clinical responses to bone marrow transplantation in children with severe osteogenesis imperfecta. , 2001, Blood.